Cancer and Pharmaceutical Sciences
Entry requirements
Bachelor's degree with 2:1 honours in a science, medicine, or dentistry (or overseas equivalent).
A 2:2 degree may be considered only where applicants also offer a Master's degree with Merit or above.
Months of entry
January, April, July, October
Course content
The overarching objective of the Comprehensive Cancer Centre is to combine research excellence with innovations in clinical practice to improve cancer patient care and therefore our research goes from basic biological research through to translational cancer research to clinical trials. We have a particular focus on tumour microenvironment, imaging and immunotherapy, which are the themes of our Cancer Research UK King's Health Partners' Cancer Centre'.
Each of the three themes within IPS includes clusters of research activity, some of which have evolved during the past decade (e.g., drug delivery, chemical biology, pharmaceutical biophysics, pharmacology), and some of which have joined KCL more recently such as enhanced activity in anticancer and anti-infective drug discovery, nanomedicines, substance abuse, health psychology, and clinical pharmacy. Researchers within and across the three themes interact both informally and via joint initiatives to promote cross-disciplinary research.
Qualification, course duration and attendance options
- MPhil/PhD
- full time36-48 months
- Campus-based learningis available for this qualification
- part time72-84 months
- Campus-based learningis available for this qualification
- MD(Res)
- full time36-48 months
- Campus-based learningis available for this qualification
- part time72-84 months
- Campus-based learningis available for this qualification
Course contact details
- Name
- Postgraduate Admissions
- admissions@kcl.ac.uk